| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |